Intramuscular Methylcobalamin Dosing
For vitamin B12 deficiency without neurological involvement, administer methylcobalamin 1 mg intramuscularly three times weekly for 2 weeks, followed by maintenance dosing of 1 mg every 2-3 months for life. 1
Clinical Context and Dosing Algorithm
The dosing regimen depends critically on whether neurological involvement is present:
Without Neurological Involvement
- Loading phase: 1 mg IM three times weekly for 2 weeks 2
- Maintenance: 1 mg IM every 2-3 months lifelong 2
The FDA-approved methylcobalamin label supports an alternative intensive regimen for pernicious anemia: 100 mcg daily for 6-7 days IM, then alternate days for seven doses, then every 3-4 days for 2-3 weeks, followed by 100 mcg monthly for life 1. However, the more recent British Obesity and Metabolic Surgery Society guidelines (2020) recommend the higher 1 mg dose with less frequent administration, which is more practical for long-term adherence 2.
With Neurological Involvement
- Intensive loading: 1 mg IM on alternate days until no further neurological improvement 2
- Maintenance: 1 mg IM every 2 months 2
Critical caveat: Neurological symptoms include unexplained sensory/motor deficits, gait disturbances, or signs of subacute combined degeneration of the spinal cord. These patients require urgent specialist consultation with neurology and hematology 2.
Important Clinical Considerations
Never administer folic acid before treating B12 deficiency - this can mask the anemia while allowing irreversible neurological damage to progress 2, 1. Always check and treat B12 deficiency first.
Route of Administration
Avoid intravenous administration - IV dosing results in almost complete urinary excretion with minimal tissue uptake 1. Intramuscular or deep subcutaneous injection is required for adequate absorption and tissue distribution 1.
Monitoring Parameters
- Baseline: Complete blood count, reticulocyte count, serum B12, folate, iron levels 1
- During treatment: Hematocrit and reticulocyte counts daily from days 5-7, then frequently until normalized 1
- Monitor serum potassium closely in first 48 hours of treatment, especially in pernicious anemia 1
Special Populations
Pregnancy/Lactation: Requirements increase to 4-5 mcg daily. Monthly IM dosing of 1 mg exceeds these needs and is safe 1. Vitamin B12 is essential and excreted in breast milk 1.
Pediatric: Intake should match recommended amounts (0.5-3 mcg daily depending on age) 1. Recent research supports sublingual methylcobalamin as an effective alternative in children, though IM remains standard 3.
Research Evidence on Dosing Frequency
A comparative study demonstrated that 500 mcg IM three times weekly produces significantly higher serum cobalamin levels (1892 ng/L) compared to 1500 mcg once weekly (1438 ng/L) in peripheral neuropathy patients 4. This supports the guideline recommendation for more frequent, lower-dose administration during the loading phase.
Higher doses (25-50 mg IM twice weekly) have been studied specifically for amyotrophic lateral sclerosis with some efficacy in early-stage disease 5, 6, but these ultra-high doses are not indicated for standard B12 deficiency treatment.
Pharmacokinetics
Methylcobalamin reaches peak plasma levels within 1 hour after IM injection 1. Bioavailability after IM administration is essentially complete (approximately 100%) 7. The liver stores vitamin B12, with reserves lasting 12-36 months without adequate intake 8.